PRELUDE CAPITAL MANAGEMENT, LLC - ACORDA THERAPEUTICS INC ownership

ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 183 filers reported holding ACORDA THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 6.95 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of ACORDA THERAPEUTICS INC
ValueSharesWeighting
Q2 2020$5,000
-58.3%
6,353
+742.6%
0.00%
-100.0%
Q4 2018$12,000
+9.1%
754
+33.2%
0.00%0.0%
Q3 2018$11,000
-74.4%
566
-68.6%
0.00%
-66.7%
Q1 2018$43,000
-41.1%
1,800
-47.1%
0.00%
-50.0%
Q4 2017$73,000
-12.0%
3,400
-2.9%
0.01%
-14.3%
Q3 2017$83,000
-58.3%
3,500
-65.3%
0.01%
-63.2%
Q2 2017$199,000
-9.1%
10,100
-3.3%
0.02%
-9.5%
Q1 2017$219,000
-35.8%
10,443
-42.5%
0.02%
-48.8%
Q4 2016$341,000
+19.2%
18,152
+61.8%
0.04%
+2.5%
Q2 2016$286,000
+472.0%
11,219
+490.5%
0.04%
+471.4%
Q1 2016$50,000
-25.4%
1,900
-5.0%
0.01%
-22.2%
Q2 2015$67,000
+42.6%
2,000
+42.9%
0.01%
+28.6%
Q1 2015$47,000
-76.0%
1,400
-70.8%
0.01%
-75.9%
Q4 2014$196,000
+20.2%
4,8000.0%0.03%
+26.1%
Q3 2014$163,000
+27.3%
4,800
+26.3%
0.02%
+35.3%
Q2 2014$128,000
+40.7%
3,800
+58.3%
0.02%
+41.7%
Q1 2014$91,000
-40.5%
2,400
-54.2%
0.01%
-52.0%
Q4 2013$153,000
-15.9%
5,243
-1.3%
0.02%
-13.8%
Q3 2013$182,000
-58.1%
5,313
-59.6%
0.03%
-68.8%
Q2 2013$434,000
-54.3%
13,159
-55.6%
0.09%
-47.5%
Q1 2013$950,00029,6590.18%
Other shareholders
ACORDA THERAPEUTICS INC shareholders Q2 2016
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 428,000$8,046,0001.90%
SCOPIA CAPITAL MANAGEMENT LP 4,532,067$85,203,0001.61%
DLD Asset Management, LP 247,300$4,656,0001.52%
Broadfin Capital, LLC 644,153$12,110,0001.34%
Perceptive Advisors 720,000$13,536,0000.96%
DLD Asset Management, LP 135,493$2,547,0000.83%
Malaga Cove Capital, LLC 51,013$971,0000.64%
Baker Brothers Advisors 3,301,791$62,074,0000.61%
Worth Venture Partners, LLC 29,300$551,0000.59%
Spark Investment Management LLC 327,900$6,164,0000.51%
View complete list of ACORDA THERAPEUTICS INC shareholders